The DOI matches its Crossref record; 211 of the 213 references it cites were found in a registry or an index.
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Abstract
As the mainstay in the treatment of various cancers, chemotherapy plays a vital role, but still faces many challenges, such as poor tumour selectivity and multidrug resistance (MDR). Targeted drug delivery using nanotechnology has provided a new strategy for addressing the limitations of the conventional chemotherapy. In the last decade, the volume of research published in this area has increased tremendously, especially with functional nano drug delivery systems (nanocarriers). Coupling a specific stimuli-triggered drug release mechanism with these delivery systems is one of the most prevalent approaches for improving therapeutic outcomes. Among the various stimuli, pH triggered delivery is regarded as the most general strategy, targeting the acidic extracellular microenvironment and intracellular organelles of solid tumours. In this review, we discuss recent advances in the development of pH-sensitive nanocarriers for tumour-targeted drug delivery. The review focuses on the chemical design of pH-sensitive biomaterials, which are used to fabricate nanocarriers for extracellular and/or intracellular tumour site-specific drug release. The pH-responsive biomaterials bring forth conformational changes in these nanocarriers through various mechanisms such as protonation, charge reversal or cleavage of a chemical bond, facilitating tumour specific cell uptake or drug release. A greater understanding of these mechanisms will help to design more efficient drug delivery systems to address the challenges encountered in conventional chemotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Acidic pH caused protonation leads to hydrophilic-hydrophobic phase transition for the anionic polymers, and hydrophobic- hydrophilic phase transition for cationic polymers, inducing deformation of amphiphilic structures leading to drug release [136].”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [136]
In the citing paper
“Generally, two basic perceptions define the mechanism of the pH-responsive nanoparticles, such as the cleavage of chemical bonds and nanocarrier protonation.138”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [138]
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,521
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
(1989) · PubMed · Cited by 3,343
Thermo- and pH-responsive polymers in drug delivery☆
SCHMALJOHANN, D. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.020 · Cited by 3,023
Danhier, F., Féron, O., & Véronique Préat, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,891
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,198
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
WICKI, A. N., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,962
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Lipid polymorphism and the functional roles of lipids in biological membranes
Cullis, P. R., & KRUIJFF, B. D. (1979) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(79)90012-1 · Cited by 1,865
Research works printed but not linked: 4
- Immordino, 2006, Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential, Int. J. Nanomedicine, 1, 297
- Liu, 2014, pH-Sensitive nano-systems for drug delivery in cancer therapy, Biotechnol. Adv., 32, 693, 10.1016/j.biotechadv.2013.11.009 · DOI · Paper page
- Sun, 2014, Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds, Biomaterials, 35, 836, 10.1016/j.biomaterials.2013.10.011 · DOI
- Carmali, 2014, Chapter 13-polyacetals, 219
Cited by
Sorted by citations
Items 101–200 of 1,000
Wang, D., Xie, W., Gao, Q., Yan, H., Zhang, J., Lu, J., Liaw, B.-S., Guo, Z., Gao, F., Yin, L., et al. (2019) · Small · doi:10.1002/smll.201900511 · Cited by 102
Wu, Z., & Li, T. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03015-x · Cited by 103
Self-citationVerkhovskii, R. A., Aa, I., Ленгерт, Е. В., Tulyakova, K. A., Shilyagina, N. Y., & Ermakov, A. V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051566 · Cited by 103
“Therefore, from this point of view, the “ideal” DDS should satisfy at least a few requirements, such as the high loading capacity, long-term circulation, diffusion into tumor interstitium, effective internalization, and sufficient drug release accompanied by specific behavior [43,122].”
BackgroundAntibody–drug conjugates in cancer therapy: current landscape, challenges, and future directions
Chen, B., Zheng, X., Wu, J., Chen, G., Yu, J. Q., Xu, Y. X., Wu, W. K. K., Tse, G. M.-K., To, K. F., & Kang, W. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02489-2 · Cited by 121
“This feature allows for higher concentrations of the drug to accumulate within the tumor, while minimizing exposure to surrounding healthy tissues [413, 414].”
Ultrafast Electrochemical Trigger Drug Delivery Mechanism for Nanographene Micromachines
Khezri, B., Beladi‐Mousavi, S. M., Krejčová, L., Heger, Z., Sofer, Z., & Pumera, M. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201806696 · Cited by 99
Liang, Y., Zhu, H., Wang, L., He, H. R., & Wang, S. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116876 · Cited by 99
Rumon, M. M. H. (2025) · RSC Advances · doi:10.1039/d5ra00521c · Cited by 108
Naseri, E., & Ahmadi, A. (2022) · European Polymer Journal · doi:10.1016/j.eurpolymj.2022.111293 · Cited by 101
Multifunctional silica nanoparticles as a promising theranostic platform for biomedical applications
Xu, Z., Ma, X., Gao, Y.-E., Hou, M., Xue, P., Li, C. M., & Kang, Y. (2017) · Materials Chemistry Frontiers · doi:10.1039/c7qm00153c · Cited by 96
Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Human Osteosarcoma
Barani, M., Mukhtar, M., Rahdar, A., Sargazi, S., Pandey, S., & Kang, M. (2021) · Biosensors · doi:10.3390/bios11020055 · Cited by 97
“These stimuli can be redox potential, tumor acidity and enzymes which trigger drug release in the tumor microenvironment [120].”
BackgroundLi, X., Wu, X., Yang, H., Li, L., Ye, Z., & Rao, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109072 · Cited by 96
Mazrad, Z. A. I., Lee, K., Chae, A., In, I., Lee, H., & Park, S. Y. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb03323k · Cited by 94
Mass spectrometry imaging of the in situ drug release from nanocarriers
Xue, J., Liu, H., Chen, S., Xiong, C., Zhan, L., Sun, J., & Nie, Z. (2018) · Science Advances · doi:10.1126/sciadv.aat9039 · Cited by 93
Making smart drugs smarter: The importance of linker chemistry in targeted drug delivery
Yang, X., Pan, Z., Choudhury, M. R., Yuan, Z., Anifowose, A., Yu, B., Wang, W., & Wang, B. (2020) · Medicinal Research Reviews · doi:10.1002/med.21720 · Cited by 96
Spatio-temporal control strategy of drug delivery systems based nano structures
Rahoui, N., Jiang, B., Taloub, N., & Huang, Y. D. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.003 · Cited by 98
Triggered Release from Cellulose Microparticles Inspired by Wood Degradation by Fungi
Qu, Q., Zhang, J., Chen, X., Ravanbakhsh, H., Tang, G., Xiong, R., Manshian, B. B., Soenen, S. J., Sauvage, F., Braeckmans, K., et al. (2020) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.0c07514 · Cited by 93
Magnetic particle targeting for diagnosis and therapy of lung cancers
Saadat, M., Manshadi, M. K. D., Mohammadi, M., Zare, M. J., Zarei, M., Kamali, R., & Sanati‐Nezhad, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.017 · Cited by 91
Costa, R. C., NAGAY, B. E., Bertolini, M., Oliveira, B. E. C., Sampaio, A. A., Retamal‐Valdes, B., Shibli, J. A., Feres, M., Barão, V. A. R., & Souza, J. G. S. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102551 · Cited by 91
Li, Y., Bui, Q. N., Duy, L. T., Yang, H. Y., & Lee, D. S. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00195 · Cited by 90
Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy
Liu, Q., Zhao, Y., Zhou, H., & Chen, C. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad004 · Cited by 94
“What’s more exciting, the various types and multiple response ranges of those acid-triggered function groups provide the diversity possible for the design of smart nanosystems to induce ferroptosis [163].”
BackgroundDNA Logic Circuits for Cancer Theranostics
Chen, J., Fu, S., Zhang, C., Liu, H., & Su, X. (2022) · Small · doi:10.1002/smll.202108008 · Cited by 90
Tumor targeting strategies for chitosan-based nanoparticles
Zhang, X., Yang, X., Ji, J., Liu, A., & Zhai, G. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.09.020 · Cited by 87
“There are a variety of approaches to realize pH-sensitivity, such as pH-sensitive materials [109] and chemical bonds [110,111].”
BackgroundWang, Z., Upputuri, P. K., Xu, Z. J., Zhang, R., Jiang, Y., Ai, X., Zhang, Z., Hu, M., Meng, Z., Lu, Y., et al. (2018) · Nano Research · doi:10.1007/s12274-018-2175-9 · Cited by 86
“4 strategy for tumor diagnostic and therapeutic purposes.[41-43] In terms of the unique pHresponsive feature of CTN, in this study, the broadband NIR-absorbing and environment-sensitive CTN could be a promising pH-activatable PA probe for specific and sensitive sensing of tumor acidic microenvironment.”
BackgroundLight-induced liposomes for cancer therapeutics
Chen, W., Goldys, E. M., & Deng, W. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101052 · Cited by 87
Microgels in biomaterials and nanomedicines
Wang, Y., Guo, L., Dong, S., Cui, J., & Hao, J. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.01.005 · Cited by 89
Stimuli-responsive switchable organic-inorganic nanocomposite materials
Lee, W., Kim, D.-J., Lee, S., Park, J., Oh, S., Kim, G., Lim, J., & Kim, J. (2018) · Nano Today · doi:10.1016/j.nantod.2018.10.006 · Cited by 85
Supramolecular nanomedicines based on host–guest interactions of cyclodextrins
Tong, F., Zhou, Y., Xu, Y., Chen, Y., Yudintceva, N. M., Shevtsov, M. A., & Gao, H. (2023) · Exploration · doi:10.1002/exp.20210111 · Cited by 84
Wang, Y., Khan, A., Liu, Y., Feng, J., Dai, L., Wang, G., Alam, N., Li, T., & Ni, Y. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115061 · Cited by 82
Bhaladhare, S., & Bhattacharjee, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.12.076 · Cited by 83
Covalent nano delivery systems for selective imaging and treatment of brain tumors
Ljubimova, J. Y., Sun, T., Mashouf, L. A., Ljubimov, A. V., Israel, L. L., Ljubimov, V. A., Falahatian, V., & Holler, E. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.002 · Cited by 82
“Release catalyzed through peptide bond cleavage by lysosomal cathepsin B ([61] and reviewed in [58]) has been considered as another pathway of paclitaxel activation and exit from endosomal compartments into the cytoplasm.”
BackgroundYan, L., Zhao, H., Zhao, X., Xu, X., Di, Y., Jiang, C., Shi, J., Shao, D., Huang, Q., Yang, H., et al. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9101-7 · Cited by 81
“widely used in a variety of biomedical and pharmaceutical applications (Kanamala et al. 2016; Zhao et al. 2013b).”
BackgroundEllis, E., Zhang, K., Lin, Q., Ye, E., Poma, A., Battaglia, G., Loh, X. J., & Lee, T. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00654c · Cited by 80
Creating CRISPR-responsive smart materials for diagnostics and programmable cargo release
Gayet, R. V., de Puig, H., English, M. A., Soenksen, L. R., Nguyen, P. Q., Mao, A. S., Angenent-Mari, N. M., & Collins, J. J. (2020) · Nature Protocols · doi:10.1038/s41596-020-0367-8 · Cited by 80
Biabanikhankahdani, R., Alitheen, N. B., Ho, K. L., & Tan, W. S. (2016) · Scientific Reports · doi:10.1038/srep37891 · Cited by 79
“= × CE% weight /weight 100% (1) FA tHBcAg particle”
Duan, Z., Zhang, Y.-H., Zhu, H., Sun, L., Cai, H., Li, B., Gong, Q., Gu, Z., & Luo, K. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b15232 · Cited by 79
Nanoscale systems for local drug delivery
Ji, T., & Kohane, D. S. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100765 · Cited by 81
Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms
Chountoulesi, M., Pispas, S., Tseti, I. K., & Demetzos, C. (2022) · Pharmaceuticals · doi:10.3390/ph15040429 · Cited by 82
Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy
Sun, Y., Sha, Y., Cui, G., Meng, F., & Zhong, Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114624 · Cited by 78
Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives
Chen, W., Sun, Z., & Lu, L. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201914511 · Cited by 79
Jiang, Z., Yuan, B., Wang, Y., Wei, Z., Sun, S., Akakuru, O. U., Li, Y., Li, J., & Wu, A. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100910 · Cited by 78
Can Bottom-Up Synthetic Biology Generate Advanced Drug-Delivery Systems?
Lussier, F., Staufer, O., Platzman, I., & Spatz, J. P. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.08.002 · Cited by 79
Versatile strategies for bioproduction of hyaluronic acid driven by synthetic biology
Yao, Z.-Y., Qin, J., Gong, J., Ye, Y.-H., Qian, J.-Y., Li, H., Xu, Z., & Shi, J. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118015 · Cited by 78
Bio-responsive smart polymers and biomedical applications
Zhang, J., Jiang, X. L., Wen, X., Xu, Q., Zeng, H., Zhao, Y., Liu, M., Wang, Z., Hu, X., & Wang, Y. (2019) · Journal of Physics Materials · doi:10.1088/2515-7639/ab1af5 · Cited by 76
Shi, J., Ren, Y., Ma, J., Luo, X., Li, J., Wu, Y., Gu, H., Fu, C., Cao, Z., & Zhang, J. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00934-0 · Cited by 77
Oroojalian, F., Karimzadeh, S., Javanbakht, S., Hejazi, M., Baradaran, B., Webster, T. J., Mokhtarzadeh, A., Varma, R. S., Kesharwani, P., & Sahebkar, A. (2022) · Materials Today · doi:10.1016/j.mattod.2022.05.024 · Cited by 77
Rezaei, A., Rafieian, F., Akbari‐Alavijeh, S., Kharazmi, M. S., & Jafari, S. M. (2022) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2022.102728 · Cited by 78
Intelligent poly(l-histidine)-based nanovehicles for controlled drug delivery
Zhang, Y., Kim, I., Lu, Y., Xu, Y., Yu, D., & Song, W. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.005 · Cited by 77
Kanamala, M., Palmer, B. D., Jamieson, S. M. F., Wilson, W. R., & Wu, Z. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0510 · Cited by 76
Self-citationRecent advances in dual- and multi-responsive nanomedicines for precision cancer therapy
Zhang, Y., Li, J., & Pu, K. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121906 · Cited by 76
Xiang, B., Jia, X., Qi, J., Yang, L., Sun, W., Yan, X., Yang, S., De-ying, C., Du, Q., & Qi, X. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129574 · Cited by 76
“Nevertheless, accumulating clinical data suggest that chemotherapy may only be able to prolong survival in a subset of patients, and the benefit of conventional chemotherapy is generally limited due to its similar cytotoxicity to both cancerous and healthy cells.(1,2) In contrast, RNA interference (RNAi) may serve as…”
BackgroundTang, M., Svirskis, D. M., Leung, E. Y., Kanamala, M., Wang, H., & Wu, Z. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.018 · Cited by 75
Self-citationZhang, M., Zhang, F., Liu, T., Shao, P., Duan, L., Yan, J., Mu, X., & Jiang, J. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s282931 · Cited by 75
Cyclotriphosphazene based materials: Structure, functionalization and applications
Wang, D., Xu, X., Qiu, Y., Wang, J., & Meng, L. (2024) · Progress in Materials Science · doi:10.1016/j.pmatsci.2024.101232 · Cited by 76
A C5N2 Nanoparticle Based Direct Nucleus Delivery Platform for Synergistic Cancer Therapy
Chen, W., Liu, J., Wang, Y., Jiang, C., Yu, B., Sun, Z., & Lu, L. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201900884 · Cited by 74
Li, K., Li, D., Zhao, L., Chang, Y., Zhang, Y., Cui, Y., & Zhang, Z. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.04.010 · Cited by 74
“Generally, there are mainly two kinds of tumor acidity-sensitive drug delivery nanoplatforms prepared from polymers with exposed protonatable−deprotonizable groups [5] or pH-trigged linkages [6].”
BackgroundLi, Y., Chen, M., Yao, B., Lu, X., Song, B., Vasilatos, S. N., Zhang, X., Ren, X., Yao, C., Bian, W., et al. (2020) · Small · doi:10.1002/smll.202002188 · Cited by 74
Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy
Chen, Z., Wang, X., Zhao, N., Chen, H., & Guo, G. F. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2292678 · Cited by 74
“However, under acidic conditions, these chemical bonds are cleaved, leading to the dissociation of nanocarriers and the subsequent release of encapsulated therapeutic agents [52].”
BackgroundChen, W., Hou, Y. X., Tu, Z., Gao, L., & Haag, R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.032 · Cited by 75
Mei, C., Wang, N., Zhu, X., Wong, K., & Chen, T. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201805225 · Cited by 74
Choi, C. A., Lee, J. E., Mazrad, Z. A. I., In, I., Jeong, J. H., & Park, S. Y. (2018) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2018.02.017 · Cited by 73
Targeted Drug Delivery via the Use of ECM-Mimetic Materials
Hwang, J., Sullivan, M. O., & Kiick, K. L. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00069 · Cited by 76
Li, J., Ying, S., Ren, H., Dai, J., Zhang, L., Liang, L., Wang, Q., Shen, Q., & Shen, J. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119241 · Cited by 73
Recent developments in stimuli-responsive polymer for emerging applications: A review
Khalil, A. K. A., Teow, Y. H., Takriff, M. S., Ahmad, A. L., & Atieh, M. A. (2025) · Results in Engineering · doi:10.1016/j.rineng.2024.103900 · Cited by 73
Miller, M. A., & Weissleder, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.023 · Cited by 74
Zhang, M., Liu, J., Kuang, Y., Li, Q., Zheng, D., Song, Q., Chen, H., Chen, X., Xu, Y., Li, C., et al. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.01.136 · Cited by 73
Mouhid, L., Corzo‐Martínez, M., Torres, C. F., Vázquez, L., Reglero, G., Fornari, T., & de Molina, A. R. (2017) · Journal of Oncology · doi:10.1155/2017/7351976 · Cited by 76
“These systems, which are called ligand-targeted liposomes, are used for specific (active or physicochemical) targeting [91, 92].”
BackgroundSwitchable Dual-Function and Bioresponsive Materials to Control Bacterial Infections
Ghasemlou, M., Daver, F., Ivanova, E. P., Rhim, J., & Adhikari, B. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05901 · Cited by 72
Zhang, R., Wang, L., Wang, X., Jia, Q., Chen, Z., Yang, Z., Ji, R., Tian, J., & Wang, Z. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000394 · Cited by 72
Liang, G., Zhu, Y., Jing, A., Wang, J., Hu, F., Feng, W., Xiao, Z., & Chen, B. (2016) · Gene Therapy · doi:10.1038/gt.2016.60 · Cited by 72
Fang, Z., Pan, S., Gao, P., Sheng, H., Li, L., Shi, L., Zhang, Y., & Cai, X. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118841 · Cited by 70
Boushehri, M. A. S., Dietrich, D., & Lamprecht, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060510 · Cited by 73
Recent advances in magnetic nanocarriers for tumor treatment
Zhu, J., Wang, J., & Li, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114227 · Cited by 71
Mahdavi, M., Fattahi, A., Tajkhorshid, E., & Nouranian, S. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00956 · Cited by 70
Davaran, S., Ghamkhari, A., Alizadeh, E., Massoumi, B., & Jaymand, M. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.11.002 · Cited by 70
“4 between the extended and collapsed state [24, 25].”
BackgroundStimuli-responsive drug delivery systems for head and neck cancer therapy
Liang, J., Yang, B., Zhou, X., Han, Q., Zou, J., & Cheng, L. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1876182 · Cited by 72
“The pH of cytoplasm or organelles are found even lower, such as endosomes (pH 5–6) and lysosomes (pH 4–5) (Matsumura & Maeda, 1986; Kanamala et al., 2016).”
BackgroundDoxorubicin-loaded micelles in tumor cell-specific chemotherapy
Almajidi, Y. Q., Kadhim, M. M., Alsaikhan, F., Jalil, A. T., Sayyid, N. H., Ramírez‐Coronel, A. A., Jawhar, Z. H., Gupta, J., Nabavi, N., Yu, W., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115722 · Cited by 73
Su, H., Zhang, W., Wu, Y., Han, X., Liu, G., Jia, Q., & Shan, S. (2018) · Journal of Biomaterials Applications · doi:10.1177/0885328218783969 · Cited by 70
Hu, F., Liu, B., Chu, H., Liu, C., Li, Z., Chen, D., & Li, L. (2019) · Nanoscale · doi:10.1039/c9nr01892a · Cited by 70
Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches
Yeini, E., Ofek, P., Albeck, N., Ajamil, D. R., Neufeld, L., Eldar‐Boock, A., Kleiner, R., Vaskovich‐Koubi, D., Koshrovski‐Michael, S., Dangoor, S. I., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000124 · Cited by 70
Precision biomaterials in cancer theranostics and modelling
Caballero, D., Abreu, C. M., Lima, A. C., Neves, N. M., Reis, R. L., & Kundu, S. C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121299 · Cited by 71
Shi, Y., Zhou, M., Zhang, Y., Wang, Y., & Cheng, J. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.12.053 · Cited by 71
Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes
Moholkar, D. N., Kandimalla, R., Gupta, R. C., & Aqil, F. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216220 · Cited by 74
Roma‐Rodrigues, C., Raposo, L. R., Cabral, R. M., Paradinha, F., Baptista, P. V., & Fernandes, A. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010162 · Cited by 72
“Using this approach, the lower pH of early endosomes when compared to the extracellular environment can be used to trigger pH-dependent drug release from the nanocarriers (reviewed in [194]).”
BackgroundPawłowska, S., Rinoldi, C., Nakielski, P., Ziai, Y., Urbanek, O., Li, X., Kowalewski, T. A., Ding, B., & Pierini, F. (2020) · Advanced Materials Interfaces · doi:10.1002/admi.202000247 · Cited by 68
Histidine-Rich Cell-Penetrating Peptide for Cancer Drug Delivery and Its Uptake Mechanism
Zhang, L., Xu, J., Wang, F., Ding, Y., Wang, T., Jin, G., Martz, M., Gui, Z., Ouyang, P., & Chen, P. (2019) · Langmuir · doi:10.1021/acs.langmuir.8b03175 · Cited by 66
pH-Responsive Amphiphilic Polyether Micelles with Superior Stability for Smart Drug Delivery
Son, I., Lee, Y., Baek, J., Park, M.-R., Han, D., Min, S. K., Lee, D., & Kim, B. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00163 · Cited by 68
Extracellular vesicle-embedded materials
Ma, Y., Brocchini, S., & Williams, G. R. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.059 · Cited by 73
“…swelling hydrogel has been studied specifically for EV delivery, such materials are promising candidates for the treatment of solid tumors or wound healing applications because the pH of injury and tumor sites is different from that of healthy tissues, and EVs can be released on demand [133,134].”
BackgroundLiu, Y., Dai, R., Wei, Q., Li, W., Zhu, G., Chi, H., Guo, Z., Wang, L., Cui, C., Xu, J., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15434 · Cited by 65
Fluorine-Doped Carbon Dots with Intrinsic Nucleus-Targeting Ability for Drug and Dye Delivery
Gao, P., Liu, S., Su, Y., Zheng, M. J., & Xie, Z. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00801 · Cited by 65
Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer Immunotherapy
Li, Q., Liu, X., Yan, C., Zhao, B., Zhao, Y., Yang, L., Shi, M., Yu, H., Li, X., & Luo, K. (2023) · Small · doi:10.1002/smll.202206211 · Cited by 68
Fabrication of zwitterionic and pH-responsive polyacetal dendrimers for anticancer drug delivery
Wang, Y., Huang, D., Wang, X., Yang, F., Shen, H. Y., & Wu, D. (2019) · Biomaterials Science · doi:10.1039/c9bm00606k · Cited by 64
Recent Progress on Activatable Nanomedicines for Immunometabolic Combinational Cancer Therapy
Zhang, C., & Pu, K. (2020) · Small Structures · doi:10.1002/sstr.202000026 · Cited by 65
Current understandings and clinical translation of nanomedicines for breast cancer therapy
Jiang, Y., Jiang, Z., Wang, M., & Ma, L. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114034 · Cited by 67
Alrbyawi, H., Poudel, I., Annaji, M., Boddu, S. H. S., Arnold, R. D., Tiwari, A. K., & Babu, R. J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061128 · Cited by 64
“However, at acidic pH, the destabilization of liposomes is facilitated by the protonation of carboxylate groups, eliminating charge repulsion in the bilayer, and subsequently resulting in the reversion of DOPE molecules into their original inverted hexagonal phase [54].”
BackgroundWei, Y., Wang, Y.-X., Xia, D., Guo, S., Wang, F., Zhang, X., & Gan, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b07132 · Cited by 64
Chen, M., Guo, Z., Chen, Q., Wei, J., Li, J., Shi, C., Xu, D., Zhou, D., Zhang, X., & Zheng, N. (2018) · Chemical Science · doi:10.1039/c8sc00104a · Cited by 64
Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye
Wang, Y., Xu, X., Gu, Y., Cheng, Y., & Cao, F. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1496080 · Cited by 65
Raucher, D., Dragojevic, S., & Ryu, J.-S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00624 · Cited by 65
Strategies To Design and Synthesize Polymer‐Based Stimuli‐Responsive Drug‐Delivery Nanosystems
Qin, X., & Li, Y. (2019) · ChemBioChem · doi:10.1002/cbic.201900550 · Cited by 63
Nano/Micromotors for Diagnosis and Therapy of Cancer and Infectious Diseases
Yuan, K., Jiang, Z., Jurado‐Sánchez, B., & Escarpa, A. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201903475 · Cited by 62
Metadata
- Authors
- Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D., & Wu, Z.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Wu, Zimei
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 85
- Pages
- 152-167
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2288119981
- Cited by
- 1,004
- References
- 213
- Citations by year
- 2026: 65 · 2025: 96 · 2024: 78 · 2023: 85 · 2022: 99 · 2021: 117 · 2020: 129 · 2019: 113 · 2018: 108 · 2017: 77 · 2016: 37
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Funders
- Royal Society of New Zealand (UOA1201)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- pH-responsive nanocarriers, tumour-targeted drug delivery, stimuli-responsive drug release, intracellular drug release, protonation, charge reversal, bond cleavage, tumor selectivity, multidrug resistance, chemotherapy
- MeSH terms
- Animals, Biocompatible Materials, Clinical Trials as Topic, Disease Models, Animal, Humans, Hydrogen-Ion Concentration, Neoplasms, Drug Delivery Systems, Nanotechnology, Nanostructures, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
